Annual Report

Aprea Therapeutics, Inc. Filed 2022-03-15 Acc 0001558370-22-003671

Documents 1

2023-03-30 10-K Annual Report
2022-03-15 10-K Annual Report
2022-03-15 8-K Results of operations
2022-03-14 4 SVP, Chief Business Officer gave up 1,989 shares (to pay taxes)
2022-03-14 4 SVP, Chief Financial Officer acquired 42,900 shares (grant or award)
2022-03-14 4 SVP, Chief Medical Officer acquired 42,900 shares (grant or award)
2021-03-16 10-K Annual Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading apre-20211231x10k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…